La Mesa City Council has unanimously voted to ban certain e-bikes for riders under the age of 12, with fines for violations ...

From Rolls-Royce to GE, our City analyst Robin Hardy finds out which of the giant engine makers are worth backing ...

It's been over a month since our last 2026 MLB mock draft, and with a significant sample size now built for this year's high ...

The EQS has received another facelift, two years after the brand’s flagship sedan/rolling test lab got revised back in April ...

The Jacksonville Jaguars are deep into the 2026 NFL Draft process, and the hay is almost in the barn. As the Jaguars continue ...

Tesla's Semi might be off to a slow start, all things considered, but it's changing minds and has real potential to disrupt ...

Investor confidence in the Asian Pacific stock market is growing, helped by easing trade tensions and signs of economic ...

Speed limits, partial beach ban, curbing 'reckless driving' behavior and more were part of an interview with Interim Chief Lance Blanchette.

Prefer Newsweek on Google to see more of our trusted coverage when you search. The failed Maxx Crosby trade may have given the Cleveland Browns a solid baseline for a potential return for Myles ...

Viktor Gyokeres has struggled to consistently deliver since joining Arsenal in a high-profile summer move to the Emirates Stadium. The striker arrived with significant expectations after scoring close ...

At least two lawsuits have been filed against San Antonio’s Valero Energy Corp. over Monday’s explosion and fire at its Port Arthur refinery. One of the complaints is a potential class action brought ...

Maze Therapeutics has revealed topline phase 2 data for its lead kidney disease candidate that has analysts heralding its “best-in-class potential.” The once-daily oral small molecule APOL1 inhibitor, ...